SCHEMBL9748783

SCHEMBL9748783

Oc1c(C2=CCCCC2)ccc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN22 Q9Y2R2 1/20 0.44
TDP1 Q9NUW8 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GRM2 Q14416 1/20 0.42
ELANE P08246 1/20 0.40
PTGS2 P35354 1/20 0.39
LDHA P00338 1/20 0.39
CLCN2 P51788 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
NFKB1 P19838 1/20 0.36
MAPK1 P28482 1/20 0.36
RAB9A P51151 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3160653 0.81 TDP1 (0.46) TDP1MEN1KMT2AGRM2ELANE
SCHEMBL19284636 0.79 IDO1 (0.46) TDP1MEN1KMT2AGRM2ELANE
SCHEMBL9620885 0.79 ELANE (0.46) TDP1MEN1KMT2AGRM2ELANE
SCHEMBL30881880 0.77 GRM2 (0.45) PTPN22TDP1MEN1KMT2AGRM2
SCHEMBL29401627 0.75 PTPN22 (0.65) PTPN22TDP1LDHACYP1A2CYP2C9
SCHEMBL374807 0.75 PTPN22 (0.65) PTPN22TDP1LDHACYP1A2CYP2C9
SCHEMBL28777035 0.75 GRM2 (0.46) TDP1GRM2ELANEPTGS2HSD17B10
SCHEMBL17733192 0.74 PTGS2 (0.43) TDP1MEN1KMT2AGRM2ELANE
SCHEMBL5206104 0.74 PTGS2 (0.42) TDP1MEN1KMT2AGRM2PTGS2
SCHEMBL5155985 0.73 PTPN22 (0.62) PTPN22TDP1LDHACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017147328-A1 COMPOUNDS FOR BINDING PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) PORTOLA PHARMACEUTICALS, INC. (US) 2017-08-31 WO disclosed
EP-0201071-B1 2-SUBSTITUTED-1-NAPHTHOLS AS 5-LIPOXYGENASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-03-04 EP disclosed
US-5026759-A Antiinflammatory agents respiratory system disorders DU PONT MERCK PHARMACEUTICAL (US) 1991-06-25 US disclosed
US-4985442-A ANTIINFLAMMATORY, LUNG DISEASES, PSORIASIS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-01-15 US disclosed
US-4985435-A TREATMENT OF INFLAMMATION, OBSTRUCTIVE LUNG DISEASES AND PSORIASIS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-01-15 US disclosed
US-4906636-A 2-Substituted-1-naphthols as 5-lipoxygenase inhibitors E. I. DU PONT DE NEMOURS AND COMPANY (US) 1990-03-06 US disclosed
US-4833164-A ANTIINFLAMMATORY AGENTS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1989-05-23 US disclosed
EP-0201071-A2 2-Substituted-1-naphthols as 5-lipoxygenase inhibitors THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1986-11-12 EP disclosed